- IRRAS will exhibit at the upcoming Congress of Neurological
Surgeons (CNS) annual meeting in San
Francisco, CA, from October 8 - 12,
2022, and the Neurocritical Care Society (NCS) annual
meeting in San Antonio, TX, on
October 17 - 21, 2022.
- IRRAS will participate in the "Neurotrauma Across the
Lifespan and Around the World" symposium at CNS on Sunday, October 9, 2022, beginning at
0800 PDT, which will provide hands-on
product training to symposium attendees.
- During CNS, Dr. Behnam Rezai
Jahromi, a neurosurgeon from Helsinki
University Hospital, will present a scientific poster titled
"Active Cerebrospinal Fluid (CSF) Exchange and Removal of
Subarachnoid Hemorrhage (SAH) to Reduce Shunt Dependency."
STOCKHOLM, Oct. 5, 2022 /PRNewswire/ -- IRRAS, a
commercial-stage medical technology company with a comprehensive
portfolio of innovative products for neurocritical care, today
announced its plans to participate in the upcoming annual meetings
of the Congress of Neurological Surgeons in San Francisco, CA, from October 8 - 12, 2022, and the Neurocritical Care
Society in San Antonio, TX, from
October 17 - 21, 2022.
Both meetings are well-respected and highly engaging conferences
that bring together neurosurgeons, neurointensivists, and other
healthcare professionals from around the world to enhance health
and improve lives through the advancement of neurosurgical
education and scientific exchange.
During CNS, IRRAS will exhibit at booth #332, and, at NCS,
IRRAS' team will be available at booth #513 to meet with attendees
and provide demonstrations of the IRRAflow and Hummingbird
neuromonitoring product lines. Attendees at both conferences
are encouraged to visit the IRRAS booths to learn more.
Also at CNS, IRRAS will participate in an all-day symposium
where international experts will present their unique perspectives
on neurotrauma management to integrate best practices and emerging
evidence to optimize outcomes. The symposium will include a product
demonstration station, where IRRAflow, the world's first
active fluid exchange system, and the Hummingbird ICP advanced
neuromonitoring product line will be showcased. Details are
provided below.
Symposium Details
Title: "SYM11: Neurotrauma Across the Lifespan and Around the
World"
Date: Sunday, October 9, 2022
Time: 0800 to 1615 PDT
Location: Moscone Center, Room 2009
In addition to the neurotrauma symposium participation at CNS,
clinical data regarding the use of the IRRAflow system
will also be presented. Dr. Behnam Rezai
Jahromi, a neurosurgeon from Helsinki
University Hospital, will present the poster, titled "Active
CSF Exchange and Removal of SAH to Reduce Shunt Dependency," which
will be available for review, both in-person and online.
"October will be an exciting month for IRRAS, and we are excited
for the opportunity to partner with the Congress of Neurological
Surgeons and the Neurocritical Care Society to participate in their
upcoming annual meetings," said Will
Martin, President and Chief Executive Officer of IRRAS. "Our
team is looking forward to meeting with attendees in person at both
of these important meetings to build brand awareness for our
IRRAflow and Hummingbird product lines and highlight the
growing commercial adoption and clinical evidence base."
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP
Monitoring product lines to hospitals worldwide through its direct
sales organization in the United
States and select European countries as well as an
international network of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
Sten Gustafsson
Director, Investor Relations
sten.gustafsson@irras.com
+46 102 11 5172
The information was released for public disclosure, through
the agency of the contact person above, on October 5, 2022, at 8:30 (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irras-announces-participation-and-educational-symposium-at-key-upcoming-neurosurgery-conferences,c3642706
View original
content:https://www.prnewswire.co.uk/news-releases/irras-announces-participation-and-educational-symposium-at-key-upcoming-neurosurgery-conferences-301641247.html